These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1720806)

  • 1. The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia.
    Cotterill AM; Holly JM; Davies SC; Coulson VJ; Price PA; Wass JA
    J Endocrinol; 1991 Nov; 131(2):303-11. PubMed ID: 1720806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
    Cotterill AM; Holly JM; Taylor AM; Davies SC; Coulson VJ; Preece MA; Wass JA; Savage MO
    J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency.
    Bang P; Brandt J; Degerblad M; Enberg G; Kaijser L; Thorén M; Hall K
    Eur J Clin Invest; 1990 Jun; 20(3):285-92. PubMed ID: 1695151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma.
    Hoekman K; van Doorn J; Gloudemans T; Maassen JA; Schuller AG; Pinedo HM
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):247-53. PubMed ID: 10468998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia.
    Cotterill AM; Holly JM; Amiel S; Wass JA
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):633-9. PubMed ID: 7687525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin.
    Hunter SJ; Daughaday WH; Callender ME; McKnight JA; McIlrath EM; Teale JD; Atkinson AB
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):397-401; discussion 402. PubMed ID: 7525121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers.
    Miell JP; Taylor AM; Jones J; Holly JM; Gaillard RC; Pralong FP; Ross RJ; Blum WF
    J Endocrinol; 1993 Mar; 136(3):525-33. PubMed ID: 7682595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
    Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
    Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
    Bach MA; Chin E; Bondy CA
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins.
    Miell JP; Taylor AM; Zini M; Maheshwari HG; Ross RJ; Valcavi R
    J Clin Endocrinol Metab; 1993 Apr; 76(4):950-5. PubMed ID: 7682563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistance.
    Quin JD; Checkley A; Gallagher A; Jones J; MacCuish AC; Miell JP
    J Endocrinol; 1994 Apr; 141(1):177-82. PubMed ID: 7516962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.
    van Buul-Offers SC; Bloemen RJ; Reijnen-Gresnigt MG; van Leiden HA; Hoogerbrugge CM; Van den Brande JL
    J Endocrinol; 1994 Oct; 143(1):191-8. PubMed ID: 7525829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of insulin-like growth factor (IGF)-I treatment on serum IGFs and IGF binding proteins in adolescent patients with growth hormone receptor deficiency.
    Wilson KF; Fielder PJ; Guevara-Aguirre J; Cohen P; Vasconez O; Martinez V; Martinez A; Rosenbloom AL; Rosenfeld RG
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):399-407. PubMed ID: 7538453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
    Gargosky SE; Nanto-Salonen K; Tapanainen P; Rosenfeld RG
    J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.